Buniyaad Healthcare Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
- Paid Up Capital ₹ 0.10 M
- Company Age 10 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.00 M
- Revenue Growth -4.95%
- Profit Growth 31.97%
- Ebitda 15.97%
- Net Worth 25.60%
- Total Assets -26.12%
About Buniyaad Healthcare
Buniyaad Healthcare Private Limited (BHPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 March 2014 and has a history of Ten years and ten months. Its registered office is in Delhi, Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.00 M.
Shruti Raj and Prashant Datta serve as directors at the Company.
Company Details
-
Location
Delhi, Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85100DL2014PTC266636
-
Company No.
266636
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
21 Mar 2014
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Buniyaad Healthcare?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shruti Raj
|
Director | 14-Sep-2022 | Current |
|
Prashant Datta
|
Director | 02-Jun-2015 | Current |
Financial Performance of Buniyaad Healthcare.
Buniyaad Healthcare Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 4.95% decrease. The company also saw a substantial improvement in profitability, with a 31.97% increase in profit. The company's net worth Soared by an impressive increase of 25.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Buniyaad Healthcare?
In 2023, Buniyaad Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Cosmic Meditech Private LimitedShruti Raj and Prashant Datta are mutual person
-
Stalwartz Nutraceuticals LlpShruti Raj is a mutual person
Charges (Loans)
₹1.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Sep 2016 | Others | ₹1.00 M | Open |
How Many Employees Work at Buniyaad Healthcare?
Unlock and access historical data on people associated with Buniyaad Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Buniyaad Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Buniyaad Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
